Moneyball Medicine: From Validation to Pharma Pipeline—How AI is Finding the Patterns in Data October 14, 2018 Podcast Harry interviews Andrew A. Radin, co-founder and CEO of twoXAR, an Artificial Intelligence driven drug discovery startup that unifies disparate data to identify potential disease treatments. READ MORE
